$2.65 0.00 (0.00%) Ohr Pharmaceutical Inc - NASDAQ

Dec. 5, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 2.65
Trade Time: Dec 05 04:00 PM Eastern Daylight Time
Change: +0.00 (0.00%)
Prev Close: 2.65
Open: 2.55
Bid: 1.15
Ask: 3.70
  1. No results found.
  1. CEO Invests in Ohr Pharmaceutical

    GuruFocus | Jan. 21, 2016 | 11:35AM EST
  2. Ohr Pharmaceutical Presents New Data From OHR-102 Phase II IMPACT Study in Wet-AMD at American Academy of Ophthalmology Annual Meeting

    Benzinga | Nov. 16, 2015 | 08:02AM EST
  3. Ohr Pharmaceutical Announces Submission of a Special Protocol Assessment and Upcoming Presentation on OHR-102 at American Academy of Ophthalmology

    Benzinga | Nov. 12, 2015 | 08:14AM EST
  4. Monday's Mid-Day Movers: Greece Reaches Deal, Dow Up Triple Digits

    Benzinga | Jul. 13, 2015 | 11:58AM EST
  5. Ohr Pharmaceutical Announces Positive Results of a Phase II Clinical Study for OHR-102 in Retinal Vein Occlusion

    Benzinga | Jul. 13, 2015 | 06:30AM EST
  6. Wall Street's Best and Worst Calls of the First Quarter 2015

    GuruFocus | May. 7, 2015 | 15:03PM EST
  7. Morning Market Gainers

    Benzinga | Mar. 2, 2015 | 09:45AM EST
  8. Benzinga's Top Initiations

    Benzinga | Feb. 26, 2015 | 09:13AM EST
  9. Roth Capital Initiates Ohr Pharmaceutical With Buy

    Benzinga | Feb. 26, 2015 | 08:47AM EST
  10. UPDATE: Chardan Capital Markets Initiates Coverage On OHR Pharmaceutical On Imminent OHR-102 Catalyst

    Benzinga | Feb. 2, 2015 | 10:26AM EST
  11. Ohr Pharmaceutical Announces New Positive Anatomic And Visual Acuity Data On OHR-102 IMPACT Study Presented At The 2014 American Academy Of Ophthalmology Scientific Meeting

    Benzinga | Oct. 20, 2014 | 06:31AM EST
  12. 3 Cheap Biotech Stocks Analysts Love: Ohr Pharmaceutical Inc, Merrimack & Amicus

    Benzinga | Sep. 8, 2014 | 13:25PM EST
  13. 4 Biotech Stocks With Big Money Coming In

    Benzinga | Jun. 30, 2014 | 14:50PM EST
  14. OHR Pharmaceutical Up 30%, Partly Recoups 2-Day Losing Streak

    Benzinga | Jun. 26, 2014 | 13:44PM EST
  15. OHR Pharmaceuticals Selling Off As Feuerstein Calls Phase II A Failure

    Benzinga | Jun. 24, 2014 | 12:17PM EST
Trading Center